For: | Iizuka M, Etou T, Sagara S. Efficacy of cytapheresis in patients with ulcerative colitis showing insufficient or lost response to biologic therapy. World J Gastroenterol 2022; 28(34): 4959-4972 [PMID: 36160647 DOI: 10.3748/wjg.v28.i34.4959] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i34/4959.htm |
Number | Citing Articles |
1 |
Joyce Wing Yan Mak, Agnes Hiu Yan Ho, Siew Chien Ng. IBD barriers across the continents – East Asia. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231212089
|
2 |
Filippo Vernia, Angelo Viscido, Giovanni Latella. Adsorptive cytapheresis in ulcerative colitis: A non‐pharmacological therapeutic approach revisited. Journal of Clinical Apheresis 2023; doi: 10.1002/jca.22091
|
3 |
Esteban Sáez‐González, Inés Moret‐Tatay, Guillermo Bastida, Mariam Aguas, Marisa Iborra, Pilar Nos, Belén Beltrán. MicroRNA and granulocyte‐monocyte adsorption apheresis combotherapy after inadequate response to anti‐TNF agents in ulcerative colitis. Journal of Clinical Apheresis 2023; doi: 10.1002/jca.22101
|
4 |
Iago Rodríguez-Lago, Leticia Abecia, Iratxe Seoane, Juan Anguita, José Luis Cabriada. An in vitro analysis of the interaction between infliximab and granulocyte–monocyte apheresis. Gastroenterología y Hepatología 2023; doi: 10.1016/j.gastrohep.2023.07.001
|